Jiangzhuo Prescription ，Fenofibrate and Placebo in the Treatment of Hyperlipidemia (Syndrome of Phlegm Obstruction)Clinical Study (JZF)
NCT01265160 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 240
Last updated 2010-12-23
Summary
Jiangzhuo prescription ,fenofibrate and placebo in the treatment of hyperlipidemia(syndrome of phlegm obstruction), randomized, parallel-controlled, multi-center clinical study
Conditions
- Metabolic Syndromes
- Hyperlipidemia
Sponsors & Collaborators
-
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2011-05-31
- Completion
- 2011-06-30
Countries
- China
Study Locations
More Related Trials
-
The Effect of Simvastatin Therapy on the Expression of Procoagulant and Inflammatory Markers in Heart Failure
NCT00769210 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)
NCT01023607 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)
NCT01341730 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design
NCT01259791 ·Status: COMPLETED ·Phase: NA
-
PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis
NCT07256197 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome
NCT05298475 ·Status: UNKNOWN ·Phase: PHASE4
-
Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
NCT01293097 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)
NCT00421278 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging
NCT00920101 ·Status: UNKNOWN ·Phase: PHASE4
-
China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension
NCT03532620 ·Status: UNKNOWN ·Phase: PHASE4
-
NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
NCT06125847 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Surem TRAF3IP2 Level and Atherosclerotic Plaque Development in Human
NCT05945394 ·Status: UNKNOWN
-
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
NCT06863545 ·Status: RECRUITING ·Phase: NA
-
Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone
NCT02232360 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)
NCT02360956 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome
NCT00444717 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis
NCT01106495 ·Status: COMPLETED ·Phase: NA
-
Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients
NCT01040936 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study for Exploring the Efficacy of Naoxintong Capsules in the Treatment of Coronary Atherosclerotic Plaque on the Basis of Optimal Medical Therapy (Aspirin,Statins,Clopidogrel, Etc.): Stage One
NCT05278182 ·Status: UNKNOWN ·Phase: NA
-
Sitosterolemia Metabolism
NCT01584206 ·Status: COMPLETED ·Phase: NA
-
Effects of Short-term Intensive Statin Therapy on Lipid Levels
NCT07344610 ·Status: RECRUITING
-
Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
NCT00926055 ·Status: WITHDRAWN ·Phase: NA
-
Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study
NCT06052020 ·Status: UNKNOWN
-
Atorvastatin in Pulmonary Hypertension
NCT00615823 ·Status: COMPLETED ·Phase: PHASE2
-
Familial Atherosclerosis Treatment Study
NCT00000512 ·Status: COMPLETED ·Phase: PHASE3